Skip to main content
Premium Trial:

Request an Annual Quote

Jay Bradner's All About the Epigenetics

Premium

In Nature, Amy Maxmen profiles Dana-Farber Cancer Institute researcher Jay Bradner, who says the way to fight cancer is to control epigenetics and essentially make cancer cells forget what their purpose is. "Findings over the past 10 years have strongly implicated dysregulation of epigenetic instructions in cancer, where growth-driving genes express like crazy and genes that keep cell division in check are silenced," Maxmen says. "Bradner's aim is to create a drug that can rewrite those instructions so that cancer cells forget what they are and cease their deadly proliferation."

This approach, Bradner suggests, could inhibit the cancer driver Myc, which has been implicated in up to 70 percent of human cancers, but has so far been found to be undruggable. "Researchers in Bradner's lab have developed a compound that interferes with Myc by manipulating epigenetic instructions," Maxmen adds. In the spirit of open research and widespread collaboration, the molecule, called JQ1, has been sent to more than 250 labs and work done on it has resulted in at least 10 published studies, she says.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.